Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Prevalence and Clinical Significance of Antineutrophil Cytoplasmic Antibodies in North American Patients with Idiopathic Pulmonary Fibrosis.

Liu GY, Ventura IB, Achtar-Zadeh N, Elicker BM, Jones KD, Wolters PJ, Collard HR, Adegunsoye A, Strek ME, Ley B.

Chest. 2019 Jun 7. pii: S0012-3692(19)31132-8. doi: 10.1016/j.chest.2019.05.014. [Epub ahead of print]

PMID:
31181198
2.

Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.

Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Soon Kim D, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Montes Worboys A, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstrong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA.

Am J Respir Crit Care Med. 2019 Apr 29. doi: 10.1164/rccm.201810-1891OC. [Epub ahead of print]

3.

Anti-RNA binding protein positivity in idiopathic interstitial pneumonia.

Bermea RS, Adegunsoye A, Oldham J, Ventura I, Lee C, Chung JH, Montner S, Noth I, Strek ME, Vij R.

Respir Med. 2019 Jan;146:23-27. doi: 10.1016/j.rmed.2018.11.015. Epub 2018 Nov 22.

PMID:
30665514
4.

Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.

Adegunsoye A, Oldham JM, Bellam SK, Montner S, Churpek MM, Noth I, Vij R, Strek ME, Chung JH.

Ann Am Thorac Soc. 2019 May;16(5):580-588. doi: 10.1513/AnnalsATS.201807-443OC.

PMID:
30653927
5.

Reply to Lescoat et al. and to Khamis et al.

Adegunsoye A, Oldham JM, Sperling AI, Noth I, Strek ME, Chung JH.

Am J Respir Crit Care Med. 2019 Apr 15;199(8):1041-1042. doi: 10.1164/rccm.201811-2208LE. No abstract available.

6.

Telomere length and genetic variant associations with interstitial lung disease progression and survival.

Newton CA, Oldham JM, Ley B, Anand V, Adegunsoye A, Liu G, Batra K, Torrealba J, Kozlitina J, Glazer C, Strek ME, Wolters PJ, Noth I, Garcia CK.

Eur Respir J. 2019 Apr 11;53(4). pii: 1801641. doi: 10.1183/13993003.01641-2018. Print 2019 Apr.

PMID:
30635297
7.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

QJM. 2019 Feb 1;112(2):81-93. doi: 10.1093/qjmed/hcy272. No abstract available.

PMID:
30605544
8.

Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.

Fischer A, Strek ME, Cottin V, Dellaripa PF, Bernstein EJ, Brown KK, Danoff SK, Distler O, Hirani N, Jones KD, Khanna D, Lee JS, Lynch DA, Maher TM, Millar AB, Raghu G, Silver RM, Steen VD, Volkmann ER, Mullan RH, O'Dwyer DN, Donnelly SC.

Arthritis Rheumatol. 2019 Feb;71(2):182-195. doi: 10.1002/art.40769. Epub 2019 Jan 3. No abstract available.

PMID:
30604506
9.

Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.

Adegunsoye A, Oldham JM, Bonham C, Hrusch C, Nolan P, Klejch W, Bellam S, Mehta U, Thakrar K, Pugashetti JV, Husain AN, Montner SM, Straus CM, Vij R, Sperling AI, Noth I, Strek ME, Chung JH.

Am J Respir Crit Care Med. 2019 Mar 15;199(6):747-759. doi: 10.1164/rccm.201804-0761OC.

PMID:
30216085
10.

Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes.

Strek ME.

Respirology. 2018 Oct;23(10):885-886. doi: 10.1111/resp.13335. Epub 2018 Jun 11. No abstract available.

11.

African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis.

Adegunsoye A, Oldham JM, Bellam SK, Chung JH, Chung PA, Biblowitz KM, Montner S, Lee C, Hsu S, Husain AN, Vij R, Mutlu G, Noth I, Churpek MM, Strek ME.

Eur Respir J. 2018 Jun 14;51(6). pii: 1800255. doi: 10.1183/13993003.00255-2018. Print 2018 Jun.

12.

CT-Pathologic Correlation of Major Types of Pulmonary Fibrosis: Insights for Revisions to Current Guidelines.

Chung JH, Oldham JM, Montner SM, Vij R, Adegunsoye A, Husain AN, Noth I, Lynch DA, Strek ME.

AJR Am J Roentgenol. 2018 May;210(5):1034-1041. doi: 10.2214/AJR.17.18947. Epub 2018 Mar 16.

PMID:
29547052
13.

Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.

Oldham JM, Adegunsoye A, Khera S, Lafond E, Noth I, Strek ME, Kadoch M, Chung JH.

Ann Am Thorac Soc. 2018 Jun;15(6):764-766. doi: 10.1513/AnnalsATS.201801-053RL. No abstract available.

14.

N-acetylcysteine exposure is associated with improved survival in anti-nuclear antibody seropositive patients with usual interstitial pneumonia.

Oldham JM, Witt LJ, Adegunsoye A, Chung JH, Lee C, Hsu S, Chen LW, Husain A, Montner S, Vij R, Strek ME, Noth I.

BMC Pulm Med. 2018 Feb 8;18(1):30. doi: 10.1186/s12890-018-0599-3.

15.

CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.

Chung JH, Cox CW, Montner SM, Adegunsoye A, Oldham JM, Husain AN, Vij R, Noth I, Lynch DA, Strek ME.

AJR Am J Roentgenol. 2018 Feb;210(2):307-313. doi: 10.2214/AJR.17.18384. Epub 2017 Nov 15.

PMID:
29140119
16.

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis.

Adegunsoye A, Oldham JM, Husain AN, Chen L, Hsu S, Montner S, Chung JH, Vij R, Noth I, Strek ME.

Front Med (Lausanne). 2017 Oct 16;4:170. doi: 10.3389/fmed.2017.00170. eCollection 2017.

17.

Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.

Adegunsoye A, Oldham JM, Chung JH, Montner SM, Lee C, Witt LJ, Stahlbaum D, Bermea RS, Chen LW, Hsu S, Husain AN, Noth I, Vij R, Strek ME, Churpek M.

Chest. 2018 Feb;153(2):349-360. doi: 10.1016/j.chest.2017.09.026. Epub 2017 Sep 28.

18.

De Novo Development of Bronchiectasis in Patients With Hematologic Malignancy.

Chen LW, McShane PJ, Karkowsky W, Gray SE, Adegunsoye A, Stock W, Artz A, White SR, Montner SM, Strek ME.

Chest. 2017 Sep;152(3):683-685. doi: 10.1016/j.chest.2017.06.042. No abstract available.

19.

Asthma Outcomes and Management During Pregnancy.

Bonham CA, Patterson KC, Strek ME.

Chest. 2018 Feb;153(2):515-527. doi: 10.1016/j.chest.2017.08.029. Epub 2017 Sep 1. Review.

20.

Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.

Sharma N, Putman MS, Vij R, Strek ME, Dua A.

J Rheumatol. 2017 Nov;44(11):1612-1618. doi: 10.3899/jrheum.161217. Epub 2017 Sep 1.

PMID:
28864644
21.

Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis.

Adegunsoye A, Oldham JM, Fernández Pérez ER, Hamblin M, Patel N, Tener M, Bhanot D, Robinson L, Bullick S, Chen L, Hsu S, Churpek M, Hedeker D, Montner S, Chung JH, Husain AN, Noth I, Strek ME, Vij R.

ERJ Open Res. 2017 Aug 17;3(3). pii: 00016-2017. doi: 10.1183/23120541.00016-2017. eCollection 2017 Jul.

22.

Allergic and Noninvasive Infectious Pulmonary Aspergillosis Syndromes.

Muldoon EG, Strek ME, Patterson KC.

Clin Chest Med. 2017 Sep;38(3):521-534. doi: 10.1016/j.ccm.2017.04.012. Epub 2017 Jun 12. Review.

PMID:
28797493
23.

CT findings associated with survival in chronic hypersensitivity pneumonitis.

Chung JH, Montner SM, Adegunsoye A, Oldham JM, Husain AN, Vij R, Noth I, Strek ME.

Eur Radiol. 2017 Dec;27(12):5127-5135. doi: 10.1007/s00330-017-4936-3. Epub 2017 Jul 7.

PMID:
28687910
24.

ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.

Hrusch CL, Manns ST, Bryazka D, Casaos J, Bonham CA, Jaffery MR, Blaine KM, Mills KAM, Verhoef PA, Adegunsoye AO, Williams JW, Tjota MY, Moore TV, Strek ME, Noth I, Sperling AI.

Mucosal Immunol. 2018 Jan;11(1):61-70. doi: 10.1038/mi.2017.42. Epub 2017 May 10.

25.

Interstitial Pneumonia With Autoimmune Features: Value of Histopathology.

Adegunsoye A, Oldham JM, Valenzi E, Lee C, Witt LJ, Chen L, Montner S, Chung JH, Noth I, Vij R, Strek ME, Husain AN.

Arch Pathol Lab Med. 2017 Jul;141(7):960-969. doi: 10.5858/arpa.2016-0427-OA. Epub 2017 May 3.

26.

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.

O'Donnell PH, Wadhwa N, Danahey K, Borden BA, Lee SM, Hall JP, Klammer C, Hussain S, Siegler M, Sorrentino MJ, Davis AM, Sacro YA, Nanda R, Polonsky TS, Koyner JL, Burnet DL, Lipstreuer K, Rubin DT, Mulcahy C, Strek ME, Harper W, Cifu AS, Polite B, Patrick-Miller L, Yeo KT, Leung E, Volchenboum SL, Altman RB, Olopade OI, Stadler WM, Meltzer DO, Ratain MJ.

Clin Pharmacol Ther. 2017 Nov;102(5):859-869. doi: 10.1002/cpt.709. Epub 2017 Jun 15.

27.

CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features.

Chung JH, Montner SM, Adegunsoye A, Lee C, Oldham JM, Husain AN, MacMahon H, Noth I, Vij R, Strek ME.

AJR Am J Roentgenol. 2017 Jun;208(6):1229-1236. doi: 10.2214/AJR.16.17121. Epub 2017 Mar 28.

28.

Skewed Lung CCR4 to CCR6 CD4+ T Cell Ratio in Idiopathic Pulmonary Fibrosis Is Associated with Pulmonary Function.

Adegunsoye A, Hrusch CL, Bonham CA, Jaffery MR, Blaine KM, Sullivan M, Churpek MM, Strek ME, Noth I, Sperling AI.

Front Immunol. 2016 Nov 23;7:516. eCollection 2016.

29.

A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria.

Strek ME, Oldham JM, Adegunsoye A, Vij R.

Eur Respir J. 2016 Dec;48(6):1813-1814. doi: 10.1183/13993003.01841-2016. No abstract available.

30.

Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.

Oldham JM, Lee C, Valenzi E, Witt LJ, Adegunsoye A, Hsu S, Chen L, Montner S, Chung JH, Noth I, Vij R, Strek ME.

Respir Med. 2016 Dec;121:117-122. doi: 10.1016/j.rmed.2016.11.007. Epub 2016 Nov 4.

31.

Comprehensive Care of the Lung Transplant Patient.

Adegunsoye A, Strek ME, Garrity E, Guzy R, Bag R.

Chest. 2017 Jul;152(1):150-164. doi: 10.1016/j.chest.2016.10.001. Epub 2016 Oct 8. Review.

32.

The Diagnosis and Treatment of Antisynthetase Syndrome.

Witt LJ, Curran JJ, Strek ME.

Clin Pulm Med. 2016 Sep;23(5):218-226.

33.

Therapeutic Approach to Adult Fibrotic Lung Diseases.

Adegunsoye A, Strek ME.

Chest. 2016 Dec;150(6):1371-1386. doi: 10.1016/j.chest.2016.07.027. Epub 2016 Aug 10. Review.

34.

Interstitial pneumonia with autoimmune features: a critical appraisal of the new definition.

Strek ME, Costabel U.

Curr Opin Pulm Med. 2016 Sep;22(5):442-9. doi: 10.1097/MCP.0000000000000298. Review.

PMID:
27379968
35.

From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.

Bonham CA, Strek ME, Patterson KC.

Curr Opin Pulm Med. 2016 Sep;22(5):484-91. doi: 10.1097/MCP.0000000000000301. Review.

36.

Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.

Adegunsoye A, Oldham JM, Demchuk C, Montner S, Vij R, Strek ME.

Respir Med. 2016 May;114:53-60. doi: 10.1016/j.rmed.2016.03.012. Epub 2016 Mar 21.

37.

Characterisation of patients with interstitial pneumonia with autoimmune features.

Oldham JM, Adegunsoye A, Valenzi E, Lee C, Witt L, Chen L, Husain AN, Montner S, Chung JH, Cottin V, Fischer A, Noth I, Vij R, Strek ME.

Eur Respir J. 2016 Jun;47(6):1767-75. doi: 10.1183/13993003.01565-2015. Epub 2016 Apr 21. Erratum in: Eur Respir J. 2017 May 11;49(5):.

38.

Response.

Oldham JM, Strek ME, Noth I.

Chest. 2016 Feb;149(2):600-601. doi: 10.1016/j.chest.2015.11.014. No abstract available.

39.

Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease.

Witt LJ, Demchuk C, Curran JJ, Strek ME.

Pulm Pharmacol Ther. 2016 Feb;36:46-52. doi: 10.1016/j.pupt.2015.12.004. Epub 2016 Jan 5.

40.

Treatment of Idiopathic Pulmonary Fibrosis.

Carlos WG, Strek ME, Wang TS, Patel H, Raghu G, Wilson KC, Thomson CC.

Ann Am Thorac Soc. 2016 Jan;13(1):115-7. doi: 10.1513/AnnalsATS.201510-713CME. No abstract available.

PMID:
26730865
41.

A functional genomic model for predicting prognosis in idiopathic pulmonary fibrosis.

Huang Y, Ma SF, Vij R, Oldham JM, Herazo-Maya J, Broderick SM, Strek ME, White SR, Hogarth DK, Sandbo NK, Lussier YA, Gibson KF, Kaminski N, Garcia JG, Noth I.

BMC Pulm Med. 2015 Nov 21;15:147. doi: 10.1186/s12890-015-0142-8.

42.

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.

Oldham JM, Ma SF, Martinez FJ, Anstrom KJ, Raghu G, Schwartz DA, Valenzi E, Witt L, Lee C, Vij R, Huang Y, Strek ME, Noth I; IPFnet Investigators.

Am J Respir Crit Care Med. 2015 Dec 15;192(12):1475-82. doi: 10.1164/rccm.201505-1010OC.

43.

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.

Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V; “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”.

Eur Respir J. 2015 Oct;46(4):976-87. doi: 10.1183/13993003.00150-2015. Epub 2015 Jul 9.

44.

Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis.

Oldham JM, Kumar D, Lee C, Patel SB, Takahashi-Manns S, Demchuk C, Strek ME, Noth I.

Chest. 2015 Sep;148(3):692-700. doi: 10.1378/chest.14-2714.

45.

Diagnosis and treatment of pulmonary aspergillosis syndromes.

Patterson KC, Strek ME.

Chest. 2014 Nov;146(5):1358-1368. doi: 10.1378/chest.14-0917. Review.

PMID:
25367472
46.

Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes.

Patterson KC, Strek ME.

Ann Am Thorac Soc. 2013 Aug;10(4):362-70. doi: 10.1513/AnnalsATS.201303-069FR. Review.

PMID:
23952859
47.

Non-cystic fibrosis bronchiectasis.

McShane PJ, Naureckas ET, Tino G, Strek ME.

Am J Respir Crit Care Med. 2013 Sep 15;188(6):647-56. doi: 10.1164/rccm.201303-0411CI. Review.

PMID:
23898922
48.

Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Vij R, Strek ME.

Chest. 2013 Mar;143(3):814-824. doi: 10.1378/chest.12-0741. Review.

49.

Improving asthma management: time for an action plan.

Strek ME.

Chest. 2012 Nov;142(5):1085-1087. doi: 10.1378/chest.12-1115. No abstract available.

PMID:
23131929
50.

Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture.

McShane PJ, Naureckas ET, Strek ME.

Chest. 2012 Jul;142(1):159-167. doi: 10.1378/chest.11-1024.

PMID:
22267679

Supplemental Content

Loading ...
Support Center